作者：
Lê,M.P. [1]
;
Solas,C. [2]
;
Garraffo,R. [3]
;
Gagnieu,M. [4]
;
Muret,P. [5]
;
Yeni,P. [6]
;
Dhiver,C. [7]
;
Katlama,C. [8]
;
Poizot-martin,I. [9]
;
Durant,J. [10]
;
Peytavin,G.
作者单位：
APHP, Bichat-Claude Bernard Hospital, Clinical Pharmacokinetic Department, EA4409 Paris 7
[1]
CHU Besancon, Clinical Pharmacology and Toxicology, Besancon, France
[2]
APHM La Timone Hospital, Pharmacokinetics and Toxicology, Aix-Marseille University, CRO2 UMR911
[3]
CHU L'Archet, Infectious Diseases, Nice, France
[4]
APHP, Bichat-Claude Bernard Hospital, Infectious Diseases, Paris, France
[5]
APHP, Pitié-Salpétrière Hospital, Infectious Diseases, Paris, France
[6]
CHU Pasteur, Pharmacology, Nice, France
[7]
CHU La Conception, Infectious Diseases, Marseille, France
[8]
CHU Sainte-Marguerite, Immuno-Hematology CISIH, Marseille, France
[9]
Hospices Civils de Lyon Edouard-Herriot Hospital, Pharmacology, Lyon, France
[10]
发布时间
2013-11-20
换一批
换一批
